Letter to the Editor
Successful treatment of Bowen's disease with ingenol mebutate 0.05% gel
Joo Hee Lee,
Joo Hee Lee
Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
Search for more papers by this author Ji Hae Lee,
Ji Hae Lee
Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
Search for more papers by this author Jung Min Bae,
Corresponding Author
Jung Min Bae
Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
Correspondence: Jung Min Bae, M.D., Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea. Email:
[email protected]Search for more papers by this author Gyong Moon Kim,
Gyong Moon Kim
Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
Search for more papers by this author
Joo Hee Lee,
Joo Hee Lee
Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
Search for more papers by this author Ji Hae Lee,
Ji Hae Lee
Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
Search for more papers by this author Jung Min Bae,
Corresponding Author
Jung Min Bae
Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
Correspondence: Jung Min Bae, M.D., Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea. Email:
[email protected]Search for more papers by this author Gyong Moon Kim,
Gyong Moon Kim
Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
Search for more papers by this author
First published: 18 May 2015
No abstract is available for this article.
References
- 1Jaeger AB, Gramkow A, Hjalgrim H, Melbye M, Frisch M. Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients. Arch Dermatol 1999; 135: 790–793.
- 2Bonerandi JJ, Beauvillain C, Caquant L et al. French Dermatology Recommendations Association (aRED): Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol 2011; 25 (Suppl 5): 1–51.
- 3Ramsay JR, Suhrbier A, Aylward JH et al. The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers. Br J Dermatol 2011; 164(3): 633–636.
- 4Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesionspecific immune response. J Am Acad Dermatol 2012; 66(3): 486–493.
- 5Siller G, Rosen R, Freeman M, Welburn P, Katsamas J, Ogbourne SM. PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial. Australas J Dermatol 2010; 51: 99–105.
